Long-term inhibition of renin-angiotensin system sustains memory function in aged Dahl rats

Hypertension

Volumn 34, Issue 3, 1999, Pages 496-502

  Hirawa, Nobuhito ^b   Uehara, Yoshio ^a   Kawabata, Yukari ^a   Numabe, Atsushi ^c   Gomi, Tomoko ^d   Ikeda, Toshio ^d   Suzuki, Tsutomu ^e   Goto, Atsuo ^a   Toyo Oka, Teruhiko ^a   Omata, Masao ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

^c DOKKYO MEDICAL UNIVERSITY   (Japan)

^d TOKYO TEISHIN HOSPITAL   (Japan)

^e NONE

Author keywords

Aging; Angiotensin converting enzyme inhibitors; Cilazapril; Cognition; Memory; Rats, aging; Receptors, angiotensin

Indexed keywords

4' [(2 CYCLOPROPYL 7 METHYL 3H IMIDAZO[4,5 B]PYRIDIN 3 YL)METHYL][1,1' BIPHENYL] 2 CARBOXYLIC ACID; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CILAZAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

AGED; AMNESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL INJURY; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG INHIBITION; ESSENTIAL HYPERTENSION; GLOMERULOSCLEROSIS; HIPPOCAMPUS; HYPERTENSION; KALLIKREIN KININ SYSTEM; MEMORY; NONHUMAN; ORAL DRUG ADMINISTRATION; PASSIVE AVOIDANCE; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM RESTRICTION;

EID: 0032885942     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.34.3.496     Document Type: Article

References (25)

1. Seno H, Ishino H, Inagaki T, Iijima M, Kaku K, Inata T. A neuropathological study of dementia in nursing homes over a 17-year period, in Shimane prefecture, Japan. Gerontology. 1999;45:44-48.
2. The GISEN Group. Randomized placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy-REIN Study. Lancet. 1997;349:1857-1863.
3. Chaturvedi N, Sjolie AK, Stephenson JM, Abrahamian H, Keipes M, Castellarin A, Rogulja-Pepeonik Z, Fuller JH. Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus. Lancet. 1998;351:28-31.
4. Tschope C, Gohlke P, Zhu YZ, Linz W, Scholkens B, Unger T. Antihypertensive and cardioprotective effects after angiotensin-converting enzyme inhibition: role of kinins. J Card Fail. 1997;3:133-148.
5. Hirawa N, Uehara Y, Kawabata Y, Oshima N, Ono H, Nagata T, Gomi T, Ikeda T, Goto A, Yagi S, Omata M. Mechanistic analysis of renal protection by angiotensin converting enzyme inhibitor in Dahl salt-sensitive rats. J Hypertens. 1994;12:909-918.
6. Hirawa N, Uehara Y, Kawabata Y, Numabe A, Oshima N, Ono H, Gomi T, Ikeda T, Yagi S, Toyo-oka T, Omata M. Subpressor dose of angiotensin II increases susceptibility to the haemodynamic injury of blood pressure in Dahl salt-sensitive rats. J Hypertens. 1995;13:81-90.
7. Ruan X, Wanger C, Chatziantoniou C, Kurtz A, Arendshorst AW. Regulation of angiotensin II receptor AT1 subtypes in renal afferent arterioles during chronic changes in sodium diet. J Clin Invest. 1997;99:1072-1081.
8. Hefti F, Fischli W, Gerold M. Cilazapril prevents hypertension in spontaneously hypertensive rats. J Cardiovasc Pharmacol. 1986;8:641-648.
9. Okunishi H, Song K, Oka Y, Kobayashi T, Kawamoto T, Ishihara H, Mori N, Miyazaki M. In vitro pharmacology of a novel non-peptide angiotensin II-receptor antagonist, E4177. Jpn J Pharmacol. 1993;62: 239-244.
10. Braszko JJ, Wisniewski K. Effects of angiotensin II and saralasin on motor activity and the passive avoidance behavior of rats. Peptides. 1988;9:475-479.
11. Tadokoro S, Kuribara H, Hayashi H. Methodological problems on learning and memory tests in rodents from view points of behavioral toxicology. In: Fujii T, Adams PM, eds. Functional Teratogenesis: Functional Effects on the Offspring After Parenteral Drug Exposure. Tokyo, Japan: Teikyo University Press; 1987:53-70.
12. Sakanaka M, Wen TC, Matsuda S, Morishita E, Nagao M, Sasaki R. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci U S A. 1998;95:4635-4640.
13. Diglio CA, Grammas P, Giacomelli F, Wiener J. Primary culture of rat cerebral microvascular endothelial cells: isolation, growth, and characterization. Lab Invest. 1982;46:554-563.
14. Morgan JM, Routtenberg A. Angiotensin injected into the neostriatum after learning disrupts retention performance. Science. 1977;196:87-89.
15. Koller M, Krause HP, Hoffmeister F, Ganten D. Endogenous brain angiotensin II disrupts passive avoidance behavior in rats. Neurosci Lett. 1979;14:71-75.
16. Wayner MJ, Armstrong DL, Polan-Curtain JL, Denny AB. Ethanol and diazepam inhibition of hippocampal LTP is mediated by angiotensin II and AT1 receptors. Peptides. 1993;14:441-444.
17. Braszko JJ, Kulakowska A, Wisniewski K. Angjotensin II and its 3-7 fragment improves recognition but not spatial memory in rats. Brain Res Bull. 1995;37:627-631.
18. Lind R, Swanson LW, Ganten D. Organization of angiotensin II immunoreactive cells and fibers in the rat central nervous system. Neuroendocrinology. 1985;40:2-24.
19. Leonetti G, Dalvetti A. Effects of cilazapril and nitrendipine on blood pressure, mood, sleep, and cognitive function in elderly hypertensive patients: an Italian multicenter study. J Cardiovasc Pharmacol. 1994; 24(suppl 3):S73-S77.
20. Wiemer G, Becker R, Gerhards H, Hock F, Stechi J, Ruger W. Effect of Hoe 065, a compound structurally related to inhibitors of angiotensin converting enzyme, on acetylcholine metabolism in rat brain. Eur J Pharmacol. 1989;166:31-39.
21. Zola-Morgan S, Squire LR, Amaral DG. Human amnesia and the medial temporal region: enduring memory impairment following a bilateral lesion limited to field CA1 of the hippocampus. J Neurosci. 1986;6: 2950-2967.
22. Tabuchi E, Endo S, Ono T, Nishijo H, Kuza S, Kogure K. Hippocampal neuronal damage after transient forebrain ischemia in monkeys. Brain Res Bull. 1992;29:685-690.
23. Sano A, Matsuda S, Wen TC, Kotani Y, Kondoh K, Ueno S, Kakimoto Y, Yoshimura H, Sakanaka M. Protection by prosaposin against ischemia-induced learning disability and neuronal loss. Biochem Biophys Res Commun. 1994;204:994-1000.
24. Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhager WH, Bulpitt CJ, de Leeuw PW, Dollery CT, Fletcher AE, Forette F, Leonetti G, Nachev C, O'Brien ET, Rosenfeld J, Rodicio JL, Tuomilehto J, Zanchetti A. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet. 1997;350:757-764.
25. Testa MA, Turner RP, Simonson DC, Krafcik MB, Calvo C, Luque-Otero M, the Nifedipine GITS Study Group. Quality of life and calcium channel blockade with nifedipine GITS versus amlodipine in hypertensive patients in Spain. J Hypertens. 1998;16:1839-1847.